Daily Stock Analysis, DVA, Davita Inc, priceseries

Davita Inc. Daily Stock Analysis
Stock Information
Open
60.48
Close
59.81
High
60.77
Low
59.17
Previous Close
61.66
Daily Price Gain
-1.85
YTD High
61.67
YTD High Date
Sep 10, 2019
YTD Low
43.40
YTD Low Date
May 31, 2019
YTD Price Change
8.08
YTD Gain
15.62%
52 Week High
79.11
52 Week High Date
Nov 7, 2018
52 Week Low
43.40
52 Week Low Date
May 31, 2019
52 Week Price Change
-7.75
52 Week Gain
-11.47%
Recent priceSeries Trade Signals

These are sample algorithmic trades based on actual market data.

Trade Type
Entry Date
Entry Price
Exit Date
Exit Price
Trade Hold Time
Gain
Trade Record
LONG
Nov 24. 2017
57.15
Jan 30. 2018
78.04
44 Trading Days
36.56%
Link
LONG
Jun 17. 2019
49.25
Jul 8. 2019
55.74
14 Trading Days
13.17%
Link
Company Information
Stock Symbol
DVA
Exchange
NYSE
Company URL
http://www.davita.com
Company Phone
310-536-2668
CEO
Kent J. Thiry
Headquarters
Colorado
Business Address
2000 16TH STREET, DENVER, CO 80202
Sector
Equity
Industry Category
Health Services
Industry Group
Specialized Health Services
CIK
0000927066
About

DaVita, Inc. engages in the provision of medical care services. It operates through Kidney Care and HealthCare Partners segments. The Kidney Care segment focuses on the delivery of dialysis services to patients with chronic kidney failure and end stage renal disease. The HealthCare Partners segment deals with the management and operation of medical groups and affiliated physician networks in California, Nevada, New Mexico, Florida, Colorado, and Washington. The company was founded in 1994 and is headquartered in Denver, CO.

Description

DaVita Inc. provides kidney dialysis services for patients suffering from chronic kidney failure or end stage renal disease (ESRD). It operates through two divisions, DaVita Kidney Care and DaVita Medical Group. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also provides outpatient, hospital inpatient, and home-based hemodialysis services; owns clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers, as well as patient and physician focused integrated health care delivery and management services. In addition, the company operates DaVita Rx, a pharmacy that provides oral medications to patients with ESRD; disease management services; vascular access services; clinical research programs; physician services; and direct primary care services. As of December 31, 2016, it provided dialysis and administrative services in the United States through a network of 2,350 outpatient dialysis centers serving approximately 187,700 patients; and operated 154 outpatient dialysis centers located in 11 countries outside of the United States. Further, the company provides acute inpatient dialysis services in approximately 900 hospitals and related laboratory services in the United States. The company was formerly known as DaVita HealthCare Partners Inc. and changed its name to DaVita Inc. in September 2016. DaVita Inc. was founded in 1994 and is headquartered in Denver, Colorado.